QIAGEN : to embrace global initiative to combat antibiotic resistance and launches cutting-edge QIAGEN Microbial Insights AR
QIAGEN today announced a new initiative to help address the global crisis of antibiotic-resistant pathogens. The Company will commit resources to support biomarker research and participate in the U.S. Centers for Disease Control and Prevention (CDC) Antimicrobial Resistance (AMR) Challenge. As a first response, QIAGEN is launching QIAGEN Microbial Insights AR (QMI-AR), an integrated genomic database that provides curated, single-point of entry access to four of the world’s largest knowledge bases on antimicrobial resistance.
AMR NEWS
Every two weeks in your inbox
Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!